Clinical Strength MiracleDry Antiperspirant Deodorant AM

Manufacturer: Highland Consumer Products | Englewood Lab, Inc.
Effective date: 2023-12-14
Label type: HUMAN OTC DRUG LABEL
Version: 7
Source: full-release
Hydrated at: 2026-06-01 00:04:18

Label at a glance#

ProductClinical Strength MiracleDry Antiperspirant Deodorant AM

Active ingredientALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY

Label structure10 sections

Indications and uses

Treats excessive perspiration and reduces underarm wetness and odor.

Dosage and administration

Apply to underarms only. Use in the morning every day. Apply few strokes to underarms after tipping bottle to get maximum effect.

Storage and handling

Keep at room temperature

Contacts and useful links#

Websitewww.miracledry.com

www.miracledry.com

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Aluminum Zirconium Octachlorohydrex Gly Anhydrous 18%

OTC - PURPOSE SECTION

Antiperspirant

Uses

INDICATIONS & USAGE SECTION

Treats excessive perspiration and reduces underarm wetness and odor.

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

on irritated skin.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away

Stop use and contact a doctor

OTC - STOP USE SECTION

if rash or irritation develops

Ask your doctor

OTC - ASK DOCTOR SECTION

before using if you have kidney disease

Directions

DOSAGE & ADMINISTRATION SECTION

Apply to underarms only. Use in the morning every day. Apply few strokes to underarms after tipping bottle to get maximum effect.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Water, PPG-11 Stearyl Ether, Cyclopentasiloxane, Steareth-2, Steareth-20, Isopropyl Myristate, Glycine, Steareth-21

Storage

STORAGE AND HANDLING SECTION

Keep at room temperature

Questions?

OTC - QUESTIONS SECTION

www.miracledry.com

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

clinical strength Miracle Dry ANTIPERSPIRANT DEODORANT AM day formula 1.7 FL OZ 50.3 ML

Product Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Miracle Dry AM

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
53897-000-01	Clinical Strength MiracleDry Antiperspirant Deodorant AM	50.3 mL in 1 BOTTLE	LIQUID	50.3		7

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
53897-000	CLINICAL STRENGTH MIRACLEDRY ANTIPERSPIRANT DEODORANT AM (ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY) LIQUID [HIGHLAND CONSUMER PRODUCTS]	7	Current NDC, Legacy NDC, 1 package rows	20231215_276ce47d-c2c3-4b3f-8861-0c83ac63ca62.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	ACTIVE INGREDIENT	P9D3YP29MY	1
ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	ACTIVE MOIETY	P9D3YP29MY	1
CYCLOMETHICONE 5	INACTIVE INGREDIENT	0THT5PCI0R	1
GLYCINE	INACTIVE INGREDIENT	TE7660XO1C	1
ISOPROPYL MYRISTATE	INACTIVE INGREDIENT	0RE8K4LNJS	1
PPG-11 STEARYL ETHER	INACTIVE INGREDIENT	S4G2J0Y0LG	1
STEARETH-2	INACTIVE INGREDIENT	V56DFE46J5	1
STEARETH-20	INACTIVE INGREDIENT	L0Q8IK9E08	1
STEARETH-21	INACTIVE INGREDIENT	53J3F32P58	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

Clinical Strength MiracleDry Antiperspirant Deodorant AM
ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY
WATER
PPG-11 STEARYL ETHER
CYCLOMETHICONE 5
STEARETH-2
STEARETH-20
ISOPROPYL MYRISTATE
GLYCINE
STEARETH-21

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
53897-000	53897-000-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
WATER	059QF0KO0R	IACT
PPG-11 STEARYL ETHER	S4G2J0Y0LG	IACT
CYCLOMETHICONE 5	0THT5PCI0R	IACT
STEARETH-2	V56DFE46J5	IACT
STEARETH-20	L0Q8IK9E08	IACT
ISOPROPYL MYRISTATE	0RE8K4LNJS	IACT
GLYCINE	TE7660XO1C	IACT
STEARETH-21	53J3F32P58	IACT
ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	P9D3YP29MY	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 84 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
GLYCINE	GLYCINE	TE7660XO1C	TABLET, CHEWABLE / ORAL		267 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	SOLUTION / ORAL	50 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	CAPSULE, DELAYED RELEASE / ORAL		50 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
STEARETH-2	STEARETH-2	V56DFE46J5	LOTION / TOPICAL	0.4 %w/w		Exact identifier — unii+route 8 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	TABLET, ORALLY DISINTEGRATING / ORAL		60 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTION, SOLUTION / INTRAVENOUS	0.42 %w/v		Exact identifier — unii candidate 40 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTABLE, LIPOSOMAL / INTRAVENOUS	0.38 %w/v		Exact identifier — unii candidate 40 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTION, SOLUTION / INTRAVENOUS	0.42 %w/v		Exact identifier — unii candidate 40 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	OIL / TOPICAL		213 mg	Exact identifier — unii+route 20 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	GEL / TOPICAL		29 mg	Exact identifier — unii+route 20 equally ranked IID candidates
STEARETH-21	STEARETH-21	53J3F32P58	LOTION / TOPICAL	3 %w/w		Exact identifier — unii+route 4 equally ranked IID candidates
STEARETH-2	STEARETH-2	V56DFE46J5	AEROSOL, FOAM / TOPICAL	1.09 %w/w		Exact identifier — unii+route 8 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	SYSTEM / TOPICAL		7 mg	Exact identifier — unii+route 20 equally ranked IID candidates
STEARETH-20	STEARETH-20	L0Q8IK9E08	CREAM / TOPICAL	4.15 %w/w		Exact identifier — unii+route 2 equally ranked IID candidates
STEARETH-21	STEARETH-21	53J3F32P58	LOTION / TOPICAL	3 %w/w		Exact identifier — unii+route 4 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	AEROSOL, SPRAY / TOPICAL	6.89 %w/w		Exact identifier — unii+route 20 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTABLE, LIPOSOMAL / INTRAVENOUS	0.38 %w/v		Exact identifier — unii candidate 40 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	TABLET / ORAL	163.31 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
PPG-11 STEARYL ETHER	POLYPROPYLENE GLYCOL 11 STEARYL ETHER	S4G2J0Y0LG	AEROSOL, FOAM / TOPICAL		750 mg	Exact identifier — unii+route 4 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	OINTMENT / TOPICAL	35 %w/w		Exact identifier — unii+route 20 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	CREAM / TOPICAL		65000 mg	Exact identifier — unii+route 20 equally ranked IID candidates
STEARETH-21	STEARETH-21	53J3F32P58	CREAM / TOPICAL	3 %w/w		Exact identifier — unii+route 4 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	CAPSULE, DELAYED RELEASE / ORAL		50 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
STEARETH-2	STEARETH-2	V56DFE46J5	CREAM / TOPICAL		643 mg	Exact identifier — unii+route 8 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTION / INTRAMUSCULAR		68 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	SOLUTION / ORAL	50 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	TABLET, ORALLY DISINTEGRATING / ORAL		60 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	3.76 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTION / INTRAVENOUS	200 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	AEROSOL, FOAM / TOPICAL		144 mg	Exact identifier — unii+route 20 equally ranked IID candidates
PPG-11 STEARYL ETHER	POLYPROPYLENE GLYCOL 11 STEARYL ETHER	S4G2J0Y0LG	AEROSOL, FOAM / TOPICAL		750 mg	Exact identifier — unii+route 4 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS	200 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	SPRAY / TOPICAL		3665 mg	Exact identifier — unii+route 20 equally ranked IID candidates
CYCLOMETHICONE 5	CYCLOMETHICONE 5	0THT5PCI0R	AEROSOL, FOAM / TOPICAL		144 mg	Exact identifier — unii+route 6 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	SPRAY / TOPICAL		3665 mg	Exact identifier — unii+route 20 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	40 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	POWDER / RESPIRATORY (INHALATION)		2 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
STEARETH-21	STEARETH-21	53J3F32P58	CREAM / TOPICAL	3 %w/w		Exact identifier — unii+route 4 equally ranked IID candidates
PPG-11 STEARYL ETHER	POLYPROPYLENE GLYCOL 11 STEARYL ETHER	S4G2J0Y0LG	SUSPENSION / TOPICAL		2288 mg	Exact identifier — unii+route 4 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTION, POWDER, FOR SOLUTION / INTRADERMAL	0.5 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
CYCLOMETHICONE 5	CYCLOMETHICONE 5	0THT5PCI0R	AEROSOL, FOAM / TOPICAL		144 mg	Exact identifier — unii+route 6 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	AEROSOL, SPRAY / TOPICAL	6.89 %w/w		Exact identifier — unii+route 20 equally ranked IID candidates
STEARETH-2	STEARETH-2	V56DFE46J5	CREAM / TOPICAL		643 mg	Exact identifier — unii+route 8 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	POWDER, FOR SOLUTION / ORAL	0.09 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	GEL / TOPICAL		29 mg	Exact identifier — unii+route 20 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTION, POWDER, FOR SOLUTION / INTRADERMAL	0.5 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	PASTE, DENTIFRICE / DENTAL	0.34 %w/w		Exact identifier — unii candidate 40 equally ranked IID candidates
STEARETH-2	STEARETH-2	V56DFE46J5	OINTMENT / TOPICAL		714 mg	Exact identifier — unii+route 8 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	CAPSULE / ORAL		62 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
CYCLOMETHICONE 5	CYCLOMETHICONE 5	0THT5PCI0R	AEROSOL / TOPICAL	2.5 %w/w		Exact identifier — unii+route 6 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	POWDER, FOR SUSPENSION / ORAL		400 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	OIL / TOPICAL		213 mg	Exact identifier — unii+route 20 equally ranked IID candidates
STEARETH-2	STEARETH-2	V56DFE46J5	AEROSOL, FOAM / TOPICAL	1.09 %w/w		Exact identifier — unii+route 8 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	POWDER, FOR SOLUTION / ORAL	0.09 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	CAPSULE / ORAL		62 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS	0.5 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTION / INTRAMUSCULAR		68 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	TABLET, CHEWABLE / ORAL		267 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	POWDER / RESPIRATORY (INHALATION)		2 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS	10 mg		Exact identifier — unii candidate 40 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Clinical Strength MiracleDry Antiperspirant Deodorant AM	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	Highland Consumer Products	276ce47d-c2c3-4b3f-8861-0c83ac63ca62	2023-12-14	Warnings	Exact identifier ndc (package): 53897-000-01 ndc (product): 53897-000 ndc11 (package): 53897000001 spl id: 0c83cb14-c7c3-3b79-e063-6394a90a4d77 spl set id: 276ce47d-c2c3-4b3f-8861-0c83ac63ca62

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.